Yüklüyor......
Formulation and clinical translation of [(177)Lu]Lu-trastuzumab for radioimmunotheranostics of metastatic breast cancer
Trastuzumab (Herceptin®) is an approved immunotherapeutic agent used for the treatment of metastatic breast cancer over-expressing HER2 antigen receptors. The aim of the present work is to standardize the formulation protocol of [(177)Lu]Lu-trastuzumab addressing various reaction parameters, evaluat...
Kaydedildi:
| Yayımlandı: | RSC Med Chem |
|---|---|
| Asıl Yazarlar: | , , , , , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
RSC
2020
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8128050/ https://ncbi.nlm.nih.gov/pubmed/34046615 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1039/d0md00319k |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|